Mechanical ventricular assistance has become a reliable tool for the support of children and infants with heart failure. The devices have shown efficacy both as a bridge to transplantation and as a bridge to recovery. The potential complications that may occur with long-term support have not been fully described. This article reports the occurrence of a large pseudoaneurysm associated with the ascending aorta following explantation of the EXCOR Pediatric ventricular assist device. A management strategy for this potentially lethal complication is described.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/2150135110372639 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mechanical circulatory support as bridge to recovery in an 8-year-old girl with tachycardia-induced cardiomyopathy due to atypical atrioventricular nodal re-entrant tachycardia: a case report.
Eur Heart J Case Rep
October 2024
Division of Pediatric Cardiology, Department of Pediatrics and Adolescent Medicine, Pediatric Heart Center Vienna, Medical University of Vienna, Waehringer Guertel 18-20, Vienna A-1090, Austria.
Article Synopsis
- Tachycardia-induced cardiomyopathy (TIC) severely affects heart function and can lead to heart failure if not managed, often requiring mechanical support or transplantation.
- In a case involving an 8-year-old girl, her heart function was critically impaired, necessitating mechanical circulatory support and eventually radiofrequency ablation of a rare tachycardia called atypical atrioventricular nodal re-entrant tachycardia (aAVNRT).
- The successful management involved careful heart rate control with medication, which allowed recovery of heart function and the safe removal of the mechanical support device.
Left ventricular assist device temporary explantation as a strategy for infection control in a pediatric patient.
J Artif Organs
September 2024
Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan.
We report a case of temporary Berlin Heart EXCOR® explantation in a pediatric patient with idiopathic dilated cardiomyopathy who suffered an uncontrollable inflow cannulation site infection while on bridge-to-transplantation. Despite failure to thrive and catheter-related infections, once free of the device, the patient was cured of infection using systemic antibiotics and surgical debridement. The patient underwent EXCOR® reimplantation after four months, and is awaiting heart transplantation in stable condition.
View Article and Find Full Text PDFSuccessful explantation of children from the Berlin Heart EXCOR® ventricular assist device: A systematic review.
Artif Organs
May 2024
Texas Center for Pediatric and Congenital Heart Disease, UT Health Austin and Dell Children's Medical Center, Austin, Texas, USA.
Background: The Berlin Heart EXCOR® (BHE) can bridge children with severe heart failure to transplantation, but some are successfully weaned and spared transplantation. This study seeks to identify characteristics of children amenable to successful explantation with BHE support.
Methods: Preferred Reporting Items for Systematic reviews and Meta-Analyses 2020 guidelines were used.
Myocardial recovery in children supported with a durable ventricular assist device-a systematic review.
Eur J Cardiothorac Surg
August 2023
Children's Hospital Zurich, Pediatric Heart Centre, Department for Congenital Heart Surgery, Zurich, Switzerland.
Objectives: A small percentage of paediatric patients supported with a ventricular assist device (VAD) can have their device explanted following myocardial recovery. The goal of this systematic review is to summarize the current literature on the clinical course in these children after weaning.
Methods: A systematic literature search was performed on 27 May 2022 using Embase, Medline ALL, Web of Science Core Collection, Cochrane Central Register of Controlled Trials and Google Scholar to include all literature on paediatric patients supported by a durable VAD during the last decade.
Cardiomyocyte deoxyribonucleic acid damage and cardiac recovery in paediatric dilated cardiomyopathy.
Eur J Cardiothorac Surg
May 2023
Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Objectives: The goal of this study was to identify the clinical significance of the deoxyribonucleic acid (DNA) damage response marker, phosphorylated H2A histone variant X, on the bridge to recovery in low-weight paediatric patients with dilated cardiomyopathy (DCM) after having a Berlin Heart EXCOR implanted.
Methods: Consecutive paediatric patients with DCM who had an EXCOR implanted for DCM at our hospital between 2013 and 2021 were reviewed. Patients were classified into 2 groups according to the degree of DNA damage in the left ventricular cardiomyocytes-the low DNA damage group and the high DNA damage group-using the median value as the threshold.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!